Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin alpha-3D chain (TUBA3D) is a protein encoded by the TUBA3D gene and is a member of the alpha-tubulin family, acting as a major component of microtubules, which are vital cytoskeletal elements in eukaryotic cells. Microtubules—composed of alpha- and beta-tubulin heterodimers—maintain cellular structure, enable intracellular transport, and mediate critical processes such as mitotic spindle formation during cell division. TUBA3D is highly expressed in the human cornea, and loss-of-function mutations are associated with the degenerative eye disease keratoconus, likely through disruption of extracellular matrix stability and aberrant matrix metalloproteinase (MMP) activity. While many chemotherapeutic drugs target tubulin (mostly via beta-tubulin), disruption of the alpha-3D isoform could influence similar cytoskeletal dynamics. Like other tubulins, TUBA3D features a GTP-binding domain and is subject to various posttranslational modifications[1][2][3][4][5]. If you need more specific information on drug binding to the TUBA3D isoform directly, this is currently limited; most approved drugs (such as taxanes) interact mainly with β-tubulin in the heterodimer, but because microtubules require both α- and β-tubulin, TUBA3D is functionally implicated[2][4].
Microtubule stabilization or destabilization (drugs like paclitaxel stabilize microtubules by binding β-tubulin, affecting α/β-tubulin dimers), Mitotic arrest (by impairing proper spindle formation)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin alpha-3D chain (TUBA3D).